People · Operator

John R. Pacifico

Named in public records as an officer, director or promoter · active 2020–2024 · Pharmaceuticals

1
Companies
4
Filings
$59.1M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Transposon Therapeutics, Inc.PharmaceuticalsSeries C$59.1M$40.6M2020
Operator network

John R. Pacifico at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Brent Ahrens · 7 companies · 1 sharedBrent AhrensDennis Podlesak · 6 companies · 1 sharedDennis PodlesakEckard Weber, M.D. · 5 companies · 1 sharedEckard Weber, M.D.Lynne Rollins · 5 companies · 1 sharedLynne RollinsKeith A. Katkin · 3 companies · 1 sharedKeith A. KatkinLynne R. Rollins · 3 companies · 1 sharedLynne R. RollinsJohn Pacifico · 2 companies · 1 sharedJohn PacificoBrent R. Ahrens · 1 companies · 1 sharedBrent R. AhrensBrian Taylor Slingsby, MD, PHD, MPH · 1 companies · 1 sharedBrian Taylor Slin…Daniel R. Hetu, MD, MBA · 1 companies · 1 sharedDaniel R. Hetu, M…Dennis Taylor Podlesak · 1 companies · 1 sharedDennis Taylor Pod…Eckard R. Weber, MD · 1 companies · 1 sharedEckard R. Weber, …William R. Harrington, MD, MBA · 1 companies · 1 sharedWilliam R. Harrin…Transposon Therapeutics, Inc. · $59.1M raisedTransposon Therapeuti…John R. PacificoJP
John R. Pacifico Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside John R. Pacifico on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brent Ahrens17
Dennis Podlesak16
Eckard Weber, M.D.15
Lynne Rollins15
Lynne R. Rollins13
Keith A. Katkin13
John Pacifico12
Daniel R. Hetu, MD, MBA11
Eckard R. Weber, MD11
Dennis Taylor Podlesak11
Brian Taylor Slingsby, MD, PHD, MPH11
William R. Harrington, MD, MBA11
Brent R. Ahrens11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.